Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Doxycycline down-regulates DNA-PK and radiosensitizes tumor initiating cells: Implications for more effective radiation therapy
Rebecca Lamb, Marco Fiorillo, Amy L. Chadwick, et al.
Oncotarget (2015) Vol. 6, Iss. 16, pp. 14005-14025
Open Access | Times Cited: 106

Showing 1-25 of 106 citing articles:

Cancer metabolism: a therapeutic perspective
Ubaldo Martinez‐Outschoorn, Maria Peiris‐Pagès, Richard G. Pestell, et al.
Nature Reviews Clinical Oncology (2016) Vol. 14, Iss. 1, pp. 11-31
Open Access | Times Cited: 1331
DNA damage response signaling pathways and targets for radiotherapy sensitization in cancer
Ruixue Huang, Ping‐Kun Zhou
Signal Transduction and Targeted Therapy (2020) Vol. 5, Iss. 1
Open Access | Times Cited: 818
Hallmarks of cancer stem cell metabolism
Patricia Sancho, David Barneda, Christopher Heeschen
British Journal of Cancer (2016) Vol. 114, Iss. 12, pp. 1305-1312
Open Access | Times Cited: 464
Impact of Mediterranean diet on metabolic syndrome, cancer and longevity
Nicola Di Daniele, Annalisa Noce, Maria Francesca Vidiri, et al.
Oncotarget (2016) Vol. 8, Iss. 5, pp. 8947-8979
Open Access | Times Cited: 281
Inhibition of cancer antioxidant defense by natural compounds
Alicja Sznarkowska, Anna Kostecka, Katarzyna Meller, et al.
Oncotarget (2016) Vol. 8, Iss. 9, pp. 15996-16016
Open Access | Times Cited: 204
Metabolism-Based Therapeutic Strategies Targeting Cancer Stem Cells
Petra Jagušt, Beatriz de Luxán‐Delgado, Beatriz Parejo-Alonso, et al.
Frontiers in Pharmacology (2019) Vol. 10
Open Access | Times Cited: 127
Mitochondrial mass, a new metabolic biomarker for stem-like cancer cells: Understanding WNT/FGF-driven anabolic signaling
Rebecca Lamb, Gloria Bonuccelli, Béla Ózsvári, et al.
Oncotarget (2015) Vol. 6, Iss. 31, pp. 30453-30471
Open Access | Times Cited: 119
Doxycycline, an Inhibitor of Mitochondrial Biogenesis, Effectively Reduces Cancer Stem Cells (CSCs) in Early Breast Cancer Patients: A Clinical Pilot Study
Cristian Scatena, Manuela Roncella, Antonello Di Paolo, et al.
Frontiers in Oncology (2018) Vol. 8
Open Access | Times Cited: 119
Bedaquiline, an FDA-approved antibiotic, inhibits mitochondrial function and potently blocks the proliferative expansion of stem-like cancer cells (CSCs)
Marco Fiorillo, Rebecca Lamb, Herbert B. Tanowitz, et al.
Aging (2016) Vol. 8, Iss. 8, pp. 1593-1607
Open Access | Times Cited: 111
Doxycycline inhibits the cancer stem cell phenotype and epithelial-to-mesenchymal transition in breast cancer
Le Zhang, Liang Xu, Fengchun Zhang, et al.
Cell Cycle (2016) Vol. 16, Iss. 8, pp. 737-745
Open Access | Times Cited: 94
New drugs are not enough‑drug repositioning in oncology: An update
Romina Armando, Diego Mengual G�mez, Daniel E. Gómez
International Journal of Oncology (2020)
Open Access | Times Cited: 81
Mitochondria as target to inhibit proliferation and induce apoptosis of cancer cells: the effects of doxycycline and gemcitabine
Sas Dijk, Margherita Protasoni, Marilena Elpidorou, et al.
Scientific Reports (2020) Vol. 10, Iss. 1
Open Access | Times Cited: 77
Mitochondrial dysfunction at the crossroad of cardiovascular diseases and cancer
Carmine Rocca, Teresa Soda, Ernestina Marianna De Francesco, et al.
Journal of Translational Medicine (2023) Vol. 21, Iss. 1
Open Access | Times Cited: 35
The role of tumor microenvironment on cancer stem cell fate in solid tumors
Sara Razi, Amin Haghparast, Sepide Chodari Khameneh, et al.
Cell Communication and Signaling (2023) Vol. 21, Iss. 1
Open Access | Times Cited: 29
Blocking the WNT/β-catenin pathway in cancer treatment:pharmacological targets and drug therapeutic potential
Xi Zhao, Yunong Ma, Jiayang Luo, et al.
Heliyon (2024) Vol. 10, Iss. 16, pp. e35989-e35989
Open Access | Times Cited: 10
Vitamin C and Doxycycline: A synthetic lethal combination therapy targeting metabolic flexibility in cancer stem cells (CSCs)
Ernestina Marianna De Francesco, Gloria Bonuccelli, Marcello Maggiolini, et al.
Oncotarget (2017) Vol. 8, Iss. 40, pp. 67269-67286
Open Access | Times Cited: 84
Mitochondrial markers predict recurrence, metastasis and tamoxifen-resistance in breast cancer patients: Early detection of treatment failure with companion diagnostics
Federica Sotgia, Marco Fiorillo, Michael P. Lisanti
Oncotarget (2017) Vol. 8, Iss. 40, pp. 68730-68745
Open Access | Times Cited: 78
Mitochondrial “power” drives tamoxifen resistance: NQO1 and GCLC are new therapeutic targets in breast cancer
Marco Fiorillo, Federica Sotgia, Diego Sisci, et al.
Oncotarget (2017) Vol. 8, Iss. 12, pp. 20309-20327
Open Access | Times Cited: 70
Doxycycline reverses epithelial-to-mesenchymal transition and suppresses the proliferation and metastasis of lung cancer cells
Yuan Qin, Qiang Zhang, Shan Lee, et al.
Oncotarget (2015) Vol. 6, Iss. 38, pp. 40667-40679
Open Access | Times Cited: 67
Doxycycline, Azithromycin and Vitamin C (DAV): A potent combination therapy for targeting mitochondria and eradicating cancer stem cells (CSCs)
Marco Fiorillo, Fanni Tóth, Federica Sotgia, et al.
Aging (2019) Vol. 11, Iss. 8, pp. 2202-2216
Open Access | Times Cited: 66
Cancer stem cell impact on clinical oncology
Mariel E. Toledo-Guzmán, Gabriele Davide Bigoni Ordóñez, Miguel Ángel Ibáñez-Hernández, et al.
World Journal of Stem Cells (2018) Vol. 10, Iss. 12, pp. 183-195
Open Access | Times Cited: 63
Matcha green tea (MGT) inhibits the propagation of cancer stem cells (CSCs), by targeting mitochondrial metabolism, glycolysis and multiple cell signalling pathways
Gloria Bonuccelli, Federica Sotgia, Michael P. Lisanti
Aging (2018) Vol. 10, Iss. 8, pp. 1867-1883
Open Access | Times Cited: 60
Repurposing of Antimicrobial Agents for Cancer Therapy: What Do We Know?
Christina Pfab, Luisa Schnobrich, Samir Eldnasoury, et al.
Cancers (2021) Vol. 13, Iss. 13, pp. 3193-3193
Open Access | Times Cited: 54
Functional Materials for Subcellular Targeting Strategies in Cancer Therapy: Progress and Prospects
Yanxiang Cheng, Zhen Qu, Jiang Qian, et al.
Advanced Materials (2023)
Closed Access | Times Cited: 21
Therapeutic effects of antibiotic drug tigecycline against cervical squamous cell carcinoma by inhibiting Wnt/β-catenin signaling
Hui Li, Shun Chang Jiao, Xin Li, et al.
Biochemical and Biophysical Research Communications (2015) Vol. 467, Iss. 1, pp. 14-20
Closed Access | Times Cited: 60
Page 1 - Next Page

Scroll to top